Articoli con mandati relativi all'accesso pubblico - Bluma BrennerUlteriori informazioni
Non disponibili pubblicamente: 10
Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance
BG Brenner, MA Wainberg
Virus research 239, 1-9, 2017
Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Subtype diversity associated with the development of HIV‐1 resistance to integrase inhibitors
BG Brenner, M Lowe, D Moisi, I Hardy, S Gagnon, H Charest, JG Baril, ...
Journal of medical virology 83 (5), 751-759, 2011
Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline
EL Asahchop, MA Wainberg, M Oliveira, H Xu, BG Brenner, D Moisi, ...
Aids 27 (6), 879-887, 2013
Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing data
AFY Poon, RA McGovern, T Mo, DJHF Knapp, B Brenner, JP Routy, ...
Aids 25 (16), 2019-2026, 2011
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
The dolutegravir R263K resistance mutation in HIV-1 integrase is incompatible with the emergence of resistance against raltegravir
M Oliveira, T Mesplède, D Moïsi, RI Ibanescu, B Brenner, MA Wainberg
AIDS 29 (17), 2255-2260, 2015
Mandati: Canadian Institutes of Health Research
HIV-1 group O resistance against integrase inhibitors
A Depatureaux, T Mesplède, P Quashie, M Oliveira, D Moisi, JC Plantier, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (1), 9-15, 2015
Mandati: Canadian Institutes of Health Research
Dolutegravir inhibits HIV-1 Env evolution in primary human cells
T Mesplède, D Moïsi, M Oliveira, I Ibanescu, F Ohnona, B Brenner, ...
AIDS 29 (6), 659-665, 2015
Mandati: Canadian Institutes of Health Research
Doravirine responses to HIV-1 viruses bearing mutations to NRTIs and NNRTIs under in vitro selective drug pressure
BG Brenner, M Oliveira, RI Ibanescu, JP Routy, R Thomas
Journal of Antimicrobial Chemotherapy 78 (8), 1921-1928, 2023
Mandati: Fonds de recherche du Québec - Santé
Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout
N Osman, T Mesplède, M Oliveira, S Hassounah, MA Wainberg, ...
AIDS 32 (13), 1773-1780, 2018
Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
New challenges in HIV research: combining phylogenetic cluster size and epidemiological data
N Parveen, EEM Moodie, J Cox, G Lambert, J Otis, M Roger, B Brenner
Epidemiologic Methods 7 (1), 20170017, 2018
Mandati: Canadian Institutes of Health Research
Disponibili pubblicamente: 67
Whole-genome sequencing reveals host factors underlying critical COVID-19
A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ...
Nature 607 (7917), 97-103, 2022
Mandati: US National Institutes of Health, UK Biotechnology and Biological Sciences …
HIV drug resistance against strand transfer integrase inhibitors
K Anstett, B Brenner, T Mesplede, MA Wainberg
Retrovirology 14, 1-16, 2017
Mandati: Canadian Institutes of Health Research
Transmission networks of drug resistance acquired in primary/early stage HIV infection
BG Brenner, M Roger, DD Moisi, M Oliveira, I Hardy, R Turgel, H Charest, ...
Aids 22 (18), 2509-2515, 2008
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Transmission clustering drives the onward spread of the HIV epidemic among men who have sex with men in Quebec
BG Brenner, M Roger, D Stephens, D Moisi, I Hardy, J Weinberg, R Turgel, ...
Journal of Infectious Diseases 204 (7), 1115-1119, 2011
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions
B Brenner, MA Wainberg, M Roger
Aids 27 (7), 1045-1057, 2013
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutations
HT Xu, EL Asahchop, M Oliveira, PK Quashie, Y Quan, BG Brenner, ...
Journal of virology 85 (21), 11300-11308, 2011
Mandati: Canadian Institutes of Health Research
Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir
M Oliveira, RI Ibanescu, K Anstett, T Mésplède, JP Routy, MA Robbins, ...
Retrovirology 15, 1-14, 2018
Mandati: Fonds de recherche du Québec - Santé, Genome Canada
Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1
D Coutsinos, CF Invernizzi, H Xu, D Moisi, M Oliveira, BG Brenner, ...
Journal of virology 83 (4), 2029-2033, 2009
Mandati: Canadian Institutes of Health Research
Antiretroviral drug resistance in human immunodeficiency virus type 2
ML Ntemgwa, TA Toni, BG Brenner, RJ Camacho, MA Wainberg
Antimicrobial agents and chemotherapy 53 (9), 3611-3619, 2009
Mandati: Canadian Institutes of Health Research
The impact of HIV genetic polymorphisms and subtype differences on the occurrence of resistance to antiretroviral drugs
MA Wainberg, BG Brenner
Molecular biology international 2012 (1), 256982, 2012
Mandati: Canadian Institutes of Health Research
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software